The estimated Net Worth of Samuel J Gesten is at least $12.1 Millón dollars as of 10 March 2023. Mr. Gesten owns over 9,531 units of Staar Surgical Co stock worth over $1,309,968 and over the last 12 years he sold STAA stock worth over $9,810,032. In addition, he makes $989,428 as Chief Legal Officer y Corporate Secretary at Staar Surgical Co.
Samuel has made over 13 trades of the Staar Surgical Co stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 9,531 units of STAA stock worth $288,885 on 10 March 2023.
The largest trade he's ever made was selling 192,522 units of Staar Surgical Co stock on 21 May 2020 worth over $7,700,880. On average, Samuel trades about 10,486 units every 126 days since 2013. As of 10 March 2023 he still owns at least 43,219 units of Staar Surgical Co stock.
You can see the complete history of Mr. Gesten stock trades at the bottom of the page.
Samuel J. Gesten serves as Chief Legal Officer, Corporate Secretary of the Company. Mr. Gesten joined STAAR in April 2012 as Vice President, General Counsel and Secretary. In May 2014, he assumed the role of Vice President of Business Development and Chief Legal Officer. In addition to these roles, Mr. Gesten serves as Chief Compliance Officer. From 2009 through 2011, he served as Executive Vice President, General Counsel and as a member of the Executive Committee of Allergan, Inc. Prior to that, he spent 11 years at Thermo Fisher Scientific Inc. in a variety of positions, including General Counsel and Assistant Secretary of the Laboratory Products Group and Vice President, Deputy General Counsel. Prior to his work at Thermo Fisher, Mr. Gesten spent 11 years practicing law. He holds a B.A. in Economics from Brandeis University and a J.D. from Boston University.
As the Chief Legal Officer y Corporate Secretary of Staar Surgical Co, the total compensation of Samuel Gesten at Staar Surgical Co is $989,428. There are 5 executives at Staar Surgical Co getting paid more, with Caren Mason having the highest compensation of $3,616,040.
Samuel Gesten is 58, he's been the Chief Legal Officer y Corporate Secretary of Staar Surgical Co since 2017. There are 10 older and 9 younger executives at Staar Surgical Co. The oldest executive at Staar Surgical Co. is John Moore, 76, who is the Independent Director.
Samuel's mailing address filed with the SEC is 25651, Atlantic Ocean Drive, Lake Forest, Orange County, California, 92630, United States.
Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal... y Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
Staar Surgical Co executives and other stock owners filed with the SEC include: